2022 Laboratory Findings- Use of Reference Range
Summary
Please see the attached briefing note. This topic will be discussed at the April SNOMED CT Editorial Advisory Group and CMAG meetings. Comments prior to support the discussion at the meetings would be very welcome.
Relevant documents
Actions:
Date | Requested action | Requester(s) | Response required by: | Comments |
|---|---|---|---|---|
23 March 2022 | Review and comment As raised on the April CMAG meeting please post comments by 25 April 2022. | @Former user (Deleted) | @Camilla Wiberg Danielsen Apr 25, 2022 @Louise Bie Apr 25, 2022 @Anna Harasim Apr 25, 2022 @Elze de Groot Apr 25, 2022 @Linda Parisien Apr 25, 2022 @susannaprnn Apr 25, 2022 @Former user (Deleted) @Jostein Ven Apr 25, 2022 @Theresa Barry Apr 25, 2022 @Libby Antoun Apr 25, 2022 @Katrien Scheerlinck (Unlicensed) Apr 25, 2022 @Eugene Viacrucis Apr 25, 2022 | Please post your comments in the Country response table below. |
Links
Initial Country Comments
Country | Date | Response |
|---|---|---|
USA | 23MAR2022 | Proposal seems reasonable and will provide consistency across SNOMED CT findings. No specific comments or reservations. |
Australia | 20220427 | We have no specific objections to the proposal. |
Ireland | 27042022 |
From a haematology perspective I am unclear on the last concept on a measurement or level that is abnormal and on that basis am unclear as to whether accept or reject this final concept proposal. |
Member countries without a CMAG rep |
Final outcome:
Date:
Copyright © 2025, SNOMED International